Researchers say Australia’s first mRNA vaccine candidate could address COVID ‘immune imprinting’

December 18, 2024 Australian Biotech

This is a preview of subscriber content

Subscribe now to continue reading.

The scientists behind Australia’s first locally developed mRNA COVID-19 vaccine candidate have published a preclinical study demonstrating the vaccine's potential to overcome the issue of ‘immune imprinting.’ …

Subscribe now to continue reading.

Latest Video

'They intended to launch a product on the market when that was not their intention'
December 16, 2024 - BioPharma
Auditor General finds the administration of the PBS 'partly effective'
December 17, 2024 - Latest News
'The demand has been higher than expected, and we’ve worked hard to make sure that it remains affordable'
December 16, 2024 - Latest News
Call for action as pneumococcal outbreak hits 20 year high
December 17, 2024 - Latest News
New listings and higher prescription volumes driving PBS spend
December 18, 2024 - Latest News

Researchers say Australia’s first mRNA vaccine candidate could address COVID ‘immune imprinting’

This is a preview of subscriber content

Latest Video

Most Read

'They intended to launch a product on the market when that was not their intention'

Auditor General finds the administration of the PBS 'partly effective'

'The demand has been higher than expected, and we’ve worked hard to make sure that it remains affordable'

Call for action as pneumococcal outbreak hits 20 year high

New listings and higher prescription volumes driving PBS spend

New Stories

Race Oncology appoints Opthea founder to its board

New listings and higher prescription volumes driving PBS spend

If you have ovarian cancer, genomic testing may open up new treatment option

Cartherics secures G-Rex grant to support its ‘in house’ manufacturing program

Researchers say Australia’s first mRNA vaccine candidate could address COVID ‘immune imprinting’

Government making it easier for itself on Safety Net but patients missing out

HTA implementation group waiting for ministerial direction on priorities

Sign In

Researchers say Australia’s first mRNA vaccine candidate could address COVID ‘immune imprinting’

This is a preview of subscriber content

Latest Video

Most Read

'They intended to launch a product on the market when that was not their intention'

Auditor General finds the administration of the PBS 'partly effective'

'The demand has been higher than expected, and we’ve worked hard to make sure that it remains affordable'

Call for action as pneumococcal outbreak hits 20 year high

New listings and higher prescription volumes driving PBS spend

Follow Us

New Stories

Race Oncology appoints Opthea founder to its board

New listings and higher prescription volumes driving PBS spend

If you have ovarian cancer, genomic testing may open up new treatment option

Cartherics secures G-Rex grant to support its ‘in house’ manufacturing program

Researchers say Australia’s first mRNA vaccine candidate could address COVID ‘immune imprinting’

Government making it easier for itself on Safety Net but patients missing out

HTA implementation group waiting for ministerial direction on priorities